NCT06124378 2025-09-24Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon CancerFirst Affiliated Hospital of Guangxi Medical UniversityPhase 2 Active not recruiting60 enrolled
NCT05914389 2023-08-08ICONICSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting100 enrolled